Novaphergan 2% dermatological cream - against insect bites and irritations 30 g

Product Description

Dermatological Cream

Composition:

100 g of cream contain: Active ingredient: promethazine hydrochloride 2.25 g equivalent to 2.0 g of promethazine base. For the full list of excipients, see section 6.1.

Excipients

Liquid paraffin; stearic acid; glycerol; xalifin 15; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; white wax; purified water; thiourea.

Therapeutic indications

Local symptomatic treatment for insect bites and other localized skin irritations such as redness, burning, itching, and sunburn.

Contraindications

NOVAPHERGAN is contraindicated in case of: – Hypersensitivity to the active ingredient or to any of the excipients or to other chemically related substances; – eczema; – secreting lesions. NOVAPHERGAN is contraindicated in children under 2 years of age.

Dosage

Apply the cream 2–3 times a day to the affected area. Avoid application on very large areas, greater than 10% of the body surface. Do not exceed the recommended dose.

Warnings and precautions

Prolonged and inappropriate use of the medicine may give rise to allergic sensitization phenomena, resulting in worsening of symptoms. If this occurs, discontinue treatment and consult your doctor to establish appropriate therapy. Since the application of NOVAPHERGAN can delay the healing process, the medicine should not be used for more than 3–4 consecutive days on lesions affected by this phenomenon. In the case of sunburn, apply the medicine and avoid further exposure of irritated skin to the sun. If rashes, irritation, and burning appear, treatment should be discontinued. Important information about some of the excipients: the medicine contains methyl p-hydroxybenzoate and propyl p-hydroxybenzoate, which may cause allergic reactions, even delayed.

Interactions

There are no known interactions with other topical drugs.

Side effects

NOVAPHERGAN may cause allergic reactions. The use of promethazine has been associated with photosensitivity reactions. Abundant application of the medicine to very large areas of the skin may cause drowsiness.

Pregnancy and breastfeeding

In pregnant women, the medicine should be used only if strictly necessary and under medical supervision.